Cadazolid
- Generic Name
- Cadazolid
- Drug Type
- Small Molecule
- Chemical Formula
- C29H29F2N3O8
- CAS Number
- 1025097-10-2
- Unique Ingredient Identifier
- 2OEA2UN10Y
- Background
Cadazolid has been used in trials studying the treatment of Clostridium Difficile Infection.
Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD)
- Conditions
- Clostridium Difficile Infection
- Interventions
- First Posted Date
- 2017-04-10
- Last Posted Date
- 2019-04-03
- Lead Sponsor
- Actelion
- Target Recruit Count
- 1
- Registration Number
- NCT03105479
- Locations
- πΊπΈ
University of Chicago, Dept. Of Medicine, Chicago, Illinois, United States
πΊπΈSUNY Upstate Medical University - Upstate Golisano Children's Hospital (GCH) - Pediatric Designated AIDS Center, Syracuse, Ohio, United States
πͺπΈHospital Sant Joan de DΓ©u, Esplugues, Barcelona, Spain
Study to Investigate the Pharmacokinetics and Safety of Cadazolid in Patients With Clostridium Difficile Infection
- First Posted Date
- 2014-02-03
- Last Posted Date
- 2014-02-03
- Lead Sponsor
- Actelion
- Target Recruit Count
- 6
- Registration Number
- NCT02053181
- Locations
- ππ·
Clinical Hospital for Infective Disease, Zagreb, Croatia
Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea
- Conditions
- Clostridium Difficile Infection
- Interventions
- First Posted Date
- 2013-11-20
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Actelion
- Target Recruit Count
- 632
- Registration Number
- NCT01987895
- Locations
- πͺπΈ
Investigator Site, Majadahonda, Spain
Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea
- Conditions
- Clostridium Difficile Infection
- Interventions
- First Posted Date
- 2013-11-14
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Actelion
- Target Recruit Count
- 631
- Registration Number
- NCT01983683
- Locations
- ππ·
Investigator Site 2784, Zagreb, Croatia
ππ·Investigator Site 2786, Zagreb, Croatia
ππ·Investigator Site 2780, Zagreb, Croatia
Efficacy, Safety and Tolerability of Cadazolid in Subjects With Clostridium Difficile Associated Diarrhea (CDAD)
- Conditions
- Clostridium Difficile Infection
- Interventions
- First Posted Date
- 2010-10-18
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- Actelion
- Target Recruit Count
- 84
- Registration Number
- NCT01222702
- Locations
- π¨π¦
Clinical Investigative Site 6601, Montreal, Quebec, Canada
πΊπΈClinical Investigative Site 6935, Marietta, Georgia, United States
πΈπͺClinical Investigative Site 6702, Orebro, Sweden
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.